Introduction To Cardiovascular Disease: Global Burden, Risk Factor, And Therapeutics Gaps

Abstract

The worldwide leading cause of both illness and death occurs because cardiovascular disease (CVD) creates significant difficulties for both healthcare systems and economic development. The CVD prevalence and burden exist because people develop cardiovascular disease through their controllable risk factors which include obesity and hypertension and dyslipidemia and diabetes and smoking and physical inactivity together with their unchangeable attributes of age and heredity and sex. The combination of traditional pharmacological and interventional therapies has developed through significant progress but the treatment process now faces "therapeutic gaps" because of drug resistance issues and bioavailability reduction and side effects and patient noncompliance. The chapter updates current CVD epidemiological research through a study of geographical prevalence differences and an assessment of unresolved problems that affect existing treatment methods. The chapter introduces research about new methods which combine nanotechnology with cardioprotective nutraceuticals to investigate new options in the book. This dialog will close existing gaps between contemporary cardiovascular medicine and its preventative healthcare solutions by presenting medical solutions which include both naturopathic and preventative therapies according to Steel observing the complete healing process. The presentation introduces a discussion about integrative approaches which combine nanotechnology and evidence-based nutraceuticals for their solution. The methods enhance drug delivery systems which result in better treatment outcomes while enabling cardiovascular prevention based on basic natural principles.